Federal Register / Vol. 72, No. 16 / Thursday, January 25, 2007 / Notices 3399 

findings for potential residual beryllium 

contamination. Appendix B–3 describes 

each facility evaluated for residual 

beryllium contamination, the data 

reviewed as a part of this evaluation, 

and the final findings. 

V. Conclusions 

The findings of this study are: (1) 

Some atomic weapons employer 

facilities and beryllium vendor facilities 

have the potential for significant 

residual radiological and beryllium 

contamination outside of the periods in 

which weapons-related production 

occurred. (2) For the purposes of this 

report, NIOSH believes that facilities 

having ‘‘significant contamination’’ had 

quantities of radioactive material that 

‘‘could have caused or substantially 

contributed to the cancer of a covered 

employee with cancer.’’ (3) The 

documents reviewed did not indicate 

the existence of a current, unrecognized 

occupational or public health threat. 

[FR Doc. E7–1157 Filed 1–24–07; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Request for Information (RFI): 

Guidance for Prioritization of Prepandemic and Pandemic Influenza 

Vaccine—Extension of Comment 

Period 

AGENCY: Office of the Secretary, 

Department of Health and Human 

Service. 

ACTION: Notice. 

SUMMARY: On December 14, 2006, the 

Department of Health and Human 

Services (HHS) issued a notice in the 

Federal Register (FR Doc. Vol. 71, No. 

240, Pages 75252–75253) to request 

input from the public on considerations 

in developing guidance for 

prioritization of the distribution and 

administration of both pre-pandemic 

and pandemic influenza vaccines based 

on various pandemic severity and 

vaccine supply scenarios. Specifically, 

HHS is seeking input on pandemic 

influenza vaccine prioritization 

considerations from all interested and 

affected parties, including but not 

limited to public health and health care 

individuals and organizations, as well 

as those from other sectors of the 

economy including, for example, travel 

and transportation, commerce and trade, 

law enforcement, emergency 

management and responders, other 

critical infrastructure sectors and the 

general public. 

Previous reports relating to pandemic 

influenza vaccine prioritization issues 

are available at http:// 

www.pandemicflu.gov. 

The purpose of this notice is to inform 

all interested parties that the comment 

period originally identified in the 

December 14, 2006 Federal Register is 

now being extended to February 5, 

2007. 

DATES: Responses should be submitted 

to the Department of Health and Human 

Services on or before 5 p.m., EDT, 

February 5, 2007. 

Instructions for Submitting 

Comments: Electronic responses are 

preferred and may be addressed to 

PandemicFlu.RFI@hhs.gov. Written 

responses should be addressed to the 

Department of Health and Human 

Services, Room 434E, 200 Independence 

Avenue, SW., Washington, DC 20201, 

Attention: Pandemic Influenza Vaccine 

Prioritization RFI. A copy of this RFI is 

also available on the PandemicFlu.Gov 

Web site and at http:// 

www.aspe.hhs.gov/PIV/rfi. Please follow 

instructions for submitting responses. 

FOR FURTHER INFORMATION CONTACT: Ben 

Schwartz, Office of Public Health and 

Science, (404) 639–8953. 

SUPPLEMENTARY INFORMATION: Extensive 

information on Federal government 

strategic and implementation plans for 

pandemic flu is available at http:// 

www.pandemicflu.gov. 

Dated: January 19, 2007. 

John O. Agwunobi, 

Assistant Secretary of Health, Office of Public 

Health and Science, Department of Health 

and Human Services. 

[FR Doc. 07–323 Filed 1–24–07; 8:45 am] 

BILLING CODE 4151–05–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Institute for Occupational 

Safety and Health (NIOSH), Safety and 

Occupational Health Study Section 

(SOHSS); Notice of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned 

committee meeting. 

Times and Dates: 8 a.m.–5 p.m., February 

20, 2007. 8 a.m.–5 p.m., February 21, 2007. 

Place: Embassy Suites Hotel, 1900 

Diagonal Road, Alexandria, Virginia, 22314, 

telephone 703.684.5900, fax 703.684.1403. 

Status: Open 8 a.m.–8:30 a.m., February 

20, 2007. Closed 8:30 a.m.–5 p.m., February 

20, 2007. Closed 8 a.m.–5 p.m., February 21, 

2007. 

Purpose: The Safety and Occupational 

Health Study Section will review, discuss, 

and evaluate grant applications received in 

response to the Institute’s standard grants 

review and funding cycles pertaining to 

research issues in occupational safety and 

health and allied areas. 

It is the intent of NIOSH to support broadbased research endeavors in keeping with the 

Institute’s program goals. This will lead to 

improved understanding and appreciation for 

the magnitude of the aggregate health burden 

associated with occupational injuries and 

illnesses, as well as to support more focused 

research projects, which will lead to 

improvements in the delivery of occupational 

safety and health services and the prevention 

of work-related injury and illness. It is 

anticipated that the research funded will 

promote these program goals. 

Matters to be Discussed: The meeting will 

convene an open session from 8–8:30 a.m. on 

February 20, 2007, to address matters related 

to the conduct of SOHSS business. The 

remainder of the meeting will proceed in 

closed session. The purpose of the closed 

session is for the study section to consider 

safety and occupational health-related grant 

applications. These portions of the meeting 

will be closed to the public in accordance 

with provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, Management 

Analysis and Services Office, Centers for 

Disease Control and Prevention, pursuant to 

Section 10(d) Pub. L. 92–463. Agenda items 

are subject to change as priorities dictate. 

For Further Information Contact: Price 

Connor, Ph.D., NIOSH Health Scientist, 1600 

Clifton Road, NE., Mailstop E–20, Atlanta, 

Georgia 30333, telephone 404.498.2511, fax 

404.498.2571. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–1083 Filed 1–24–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

In compliance with Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 concerning 

opportunity for public comment on 

proposed collections of information, the 


ycherry on PROD1PC64 with NOTICES